SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
星河zp
Lv1
60 积分
2023-07-14 加入
最近求助
最近应助
互助留言
Splenectomy in gynecologic oncology: Indications, complications, and technique
10天前
已完结
Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies
11天前
已完结
Pushing the CART to the Finish Line: Integrating Radiation Therapy Into Chimeric Antigen Receptor T-Cell Therapy Programs to Improve Outcomes for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
13天前
已完结
Improvements in Patient-Reported Outcomes in Relapsed or Refractory Large B-Cell Lymphoma Patients Treated With Epcoritamab
13天前
已完结
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis
18天前
已完结
Ivosidénib pour le traitement des cholangiocarcinomes avec une mutation IDH1 R132 préalablement traités
19天前
已完结
Emerging Biomarkers for Monitoring Chimeric Antigen Receptor T-Cell Therapy
19天前
已完结
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
21天前
已完结
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab
26天前
已完结
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
26天前
已完结
没有进行任何应助
不需要了【积分已退回】
30天前
不需要了【积分已退回】
2个月前
标题错了【积分已退回】
5个月前
输错内容【积分已退回】
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论